Gyorgy Frendl, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acute Kidney Injury | 8 | 2020 | 1942 | 1.160 |
Why?
|
Thoracic Surgical Procedures | 3 | 2014 | 350 | 0.990 |
Why?
|
Atrial Flutter | 2 | 2014 | 253 | 0.790 |
Why?
|
Pulmonary Atelectasis | 1 | 2022 | 160 | 0.740 |
Why?
|
Electric Countershock | 2 | 2014 | 534 | 0.740 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2014 | 775 | 0.680 |
Why?
|
Pneumonectomy | 6 | 2025 | 1156 | 0.590 |
Why?
|
Thrombelastography | 1 | 2019 | 194 | 0.550 |
Why?
|
Sepsis | 6 | 2022 | 2608 | 0.540 |
Why?
|
Cardiac Surgical Procedures | 4 | 2019 | 3683 | 0.490 |
Why?
|
Thromboembolism | 1 | 2019 | 1004 | 0.410 |
Why?
|
Interleukin-6 | 2 | 2022 | 3228 | 0.400 |
Why?
|
Pleural Neoplasms | 2 | 2020 | 612 | 0.400 |
Why?
|
Antithrombins | 2 | 2013 | 294 | 0.360 |
Why?
|
Postoperative Complications | 10 | 2025 | 15832 | 0.360 |
Why?
|
Catheter Ablation | 2 | 2014 | 2780 | 0.360 |
Why?
|
Patient Simulation | 1 | 2013 | 297 | 0.360 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2014 | 489 | 0.350 |
Why?
|
Pneumonia, Bacterial | 1 | 2013 | 320 | 0.350 |
Why?
|
Intensive Care Units | 7 | 2022 | 3800 | 0.330 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2012 | 452 | 0.320 |
Why?
|
Anesthetics | 1 | 2014 | 525 | 0.320 |
Why?
|
Receptors, GABA-A | 1 | 2013 | 625 | 0.320 |
Why?
|
Thrombosis | 1 | 2022 | 2957 | 0.310 |
Why?
|
Anesthesiology | 2 | 2016 | 1137 | 0.280 |
Why?
|
Benzodiazepines | 1 | 2013 | 1138 | 0.280 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2013 | 1141 | 0.270 |
Why?
|
Creatinine | 1 | 2012 | 1918 | 0.260 |
Why?
|
Mesothelioma | 1 | 2012 | 811 | 0.250 |
Why?
|
Oxygen Inhalation Therapy | 3 | 2025 | 418 | 0.250 |
Why?
|
Atrial Fibrillation | 2 | 2014 | 5176 | 0.250 |
Why?
|
Interleukin-3 | 3 | 1992 | 425 | 0.250 |
Why?
|
Delirium | 1 | 2016 | 1697 | 0.230 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2298 | 0.220 |
Why?
|
Cisplatin | 3 | 2020 | 1660 | 0.210 |
Why?
|
Peptide Fragments | 2 | 2013 | 5151 | 0.210 |
Why?
|
Ovarian Neoplasms | 2 | 2017 | 4916 | 0.190 |
Why?
|
Positive-Pressure Respiration | 2 | 2024 | 713 | 0.190 |
Why?
|
Hirudins | 2 | 2013 | 179 | 0.180 |
Why?
|
Echocardiography | 1 | 2013 | 5047 | 0.180 |
Why?
|
Computer Simulation | 2 | 2013 | 6283 | 0.180 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2003 | 621 | 0.180 |
Why?
|
Macrophage Activation | 3 | 1992 | 557 | 0.160 |
Why?
|
Propensity Score | 2 | 2025 | 1969 | 0.160 |
Why?
|
Anesthesia, Conduction | 1 | 2022 | 263 | 0.160 |
Why?
|
Critical Illness | 2 | 2022 | 2756 | 0.150 |
Why?
|
Baths | 1 | 2018 | 52 | 0.150 |
Why?
|
Kidney | 3 | 2019 | 7064 | 0.140 |
Why?
|
Theophylline | 1 | 2017 | 133 | 0.140 |
Why?
|
Cross Infection | 2 | 2018 | 1426 | 0.140 |
Why?
|
Predictive Value of Tests | 6 | 2017 | 15454 | 0.140 |
Why?
|
Chlorhexidine | 1 | 2018 | 159 | 0.140 |
Why?
|
Serum | 1 | 2017 | 206 | 0.130 |
Why?
|
Oxygen | 2 | 2025 | 4270 | 0.130 |
Why?
|
Humans | 47 | 2025 | 768166 | 0.130 |
Why?
|
Lung Diseases | 2 | 2017 | 1944 | 0.120 |
Why?
|
Complement Membrane Attack Complex | 1 | 1995 | 105 | 0.120 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2016 | 87 | 0.120 |
Why?
|
Resuscitation | 1 | 2019 | 679 | 0.120 |
Why?
|
Liver Diseases | 1 | 2002 | 1305 | 0.110 |
Why?
|
Goals | 1 | 2019 | 717 | 0.110 |
Why?
|
Societies, Medical | 3 | 2014 | 3968 | 0.110 |
Why?
|
Retrospective Studies | 9 | 2025 | 81762 | 0.110 |
Why?
|
Bronchodilator Agents | 1 | 2017 | 518 | 0.110 |
Why?
|
Blood Coagulation | 1 | 2019 | 1162 | 0.110 |
Why?
|
Complement Activation | 1 | 1995 | 447 | 0.110 |
Why?
|
Computer-Assisted Instruction | 1 | 2016 | 366 | 0.110 |
Why?
|
Critical Care | 4 | 2018 | 2715 | 0.110 |
Why?
|
Macrophages | 4 | 1992 | 5799 | 0.100 |
Why?
|
Thoracostomy | 1 | 2013 | 79 | 0.100 |
Why?
|
Pneumothorax | 1 | 2016 | 393 | 0.100 |
Why?
|
Cefazolin | 1 | 2013 | 95 | 0.100 |
Why?
|
Chest Tubes | 1 | 2013 | 153 | 0.100 |
Why?
|
Disease Transmission, Infectious | 1 | 2018 | 560 | 0.100 |
Why?
|
Nitric Oxide | 3 | 2003 | 2146 | 0.100 |
Why?
|
Acetaminophen | 1 | 2016 | 552 | 0.100 |
Why?
|
Lung | 2 | 2024 | 10099 | 0.100 |
Why?
|
Preoperative Period | 1 | 2014 | 565 | 0.100 |
Why?
|
Lipopolysaccharides | 4 | 2002 | 2219 | 0.100 |
Why?
|
Pharmacists | 1 | 2014 | 261 | 0.090 |
Why?
|
Professional Role | 1 | 2014 | 316 | 0.090 |
Why?
|
Video Recording | 1 | 2016 | 976 | 0.090 |
Why?
|
Disease Progression | 2 | 2018 | 13671 | 0.090 |
Why?
|
Bacteremia | 1 | 2018 | 986 | 0.090 |
Why?
|
Vasodilation | 1 | 1995 | 967 | 0.090 |
Why?
|
MicroRNAs | 2 | 2017 | 3803 | 0.090 |
Why?
|
Abdomen | 1 | 2017 | 1136 | 0.090 |
Why?
|
Infection Control | 1 | 2018 | 985 | 0.090 |
Why?
|
Receptors, Leukocyte-Adhesion | 1 | 1990 | 53 | 0.090 |
Why?
|
Interleukin-1 | 3 | 1992 | 1252 | 0.090 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2014 | 278 | 0.090 |
Why?
|
Partial Thromboplastin Time | 1 | 2011 | 204 | 0.090 |
Why?
|
Fungemia | 1 | 2010 | 57 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2014 | 497 | 0.090 |
Why?
|
Drug Resistance, Fungal | 1 | 2010 | 78 | 0.080 |
Why?
|
Female | 26 | 2025 | 397192 | 0.080 |
Why?
|
Middle Aged | 20 | 2025 | 223492 | 0.080 |
Why?
|
Medical Staff, Hospital | 1 | 2014 | 603 | 0.080 |
Why?
|
Withholding Treatment | 1 | 2014 | 620 | 0.080 |
Why?
|
Fluconazole | 1 | 2010 | 156 | 0.080 |
Why?
|
Cardiopulmonary Bypass | 1 | 2015 | 1097 | 0.080 |
Why?
|
Patient Admission | 1 | 2016 | 1365 | 0.080 |
Why?
|
Aged | 17 | 2025 | 171504 | 0.080 |
Why?
|
Candida | 1 | 2010 | 173 | 0.080 |
Why?
|
Risk Assessment | 4 | 2014 | 24315 | 0.080 |
Why?
|
Hemodynamics | 2 | 2014 | 4194 | 0.080 |
Why?
|
Fibrinogen | 1 | 2012 | 891 | 0.080 |
Why?
|
Prospective Studies | 9 | 2024 | 54926 | 0.080 |
Why?
|
Antibiotic Prophylaxis | 1 | 2013 | 640 | 0.070 |
Why?
|
Male | 24 | 2025 | 364719 | 0.070 |
Why?
|
Communication | 2 | 2014 | 3905 | 0.070 |
Why?
|
Candidiasis | 1 | 2010 | 367 | 0.070 |
Why?
|
Risk Factors | 7 | 2025 | 74944 | 0.070 |
Why?
|
Antigens, Differentiation | 1 | 1990 | 921 | 0.070 |
Why?
|
Sex Distribution | 1 | 2012 | 2278 | 0.070 |
Why?
|
Orthopedic Procedures | 1 | 2017 | 1279 | 0.070 |
Why?
|
Rare Diseases | 1 | 2012 | 631 | 0.070 |
Why?
|
Age Distribution | 1 | 2012 | 2873 | 0.070 |
Why?
|
Iron | 1 | 2015 | 1813 | 0.070 |
Why?
|
Recombinant Proteins | 2 | 2013 | 6514 | 0.060 |
Why?
|
Hospital Mortality | 2 | 2017 | 5349 | 0.060 |
Why?
|
Blood Gas Analysis | 1 | 2007 | 384 | 0.060 |
Why?
|
Neurosurgical Procedures | 1 | 2017 | 2076 | 0.060 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1990 | 1441 | 0.060 |
Why?
|
Taiwan | 2 | 2017 | 521 | 0.060 |
Why?
|
Aged, 80 and over | 8 | 2018 | 59629 | 0.060 |
Why?
|
Pulmonary Artery | 1 | 2014 | 1946 | 0.060 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 981 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2018 | 65371 | 0.060 |
Why?
|
Antifungal Agents | 1 | 2010 | 761 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2014 | 7477 | 0.060 |
Why?
|
Terminology as Topic | 1 | 2012 | 1542 | 0.060 |
Why?
|
Respiration, Artificial | 3 | 2025 | 2726 | 0.060 |
Why?
|
Incidence | 3 | 2024 | 21538 | 0.060 |
Why?
|
Postoperative Period | 2 | 2022 | 1826 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2420 | 0.060 |
Why?
|
Surgical Wound Infection | 1 | 2013 | 1546 | 0.060 |
Why?
|
Coronary Vessels | 1 | 1995 | 3124 | 0.050 |
Why?
|
Ultrasonography | 1 | 2016 | 6004 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 1995 | 4427 | 0.050 |
Why?
|
Linear Models | 1 | 2013 | 5884 | 0.050 |
Why?
|
Thrombocytopenia | 1 | 2011 | 1179 | 0.050 |
Why?
|
Inflammation | 1 | 2022 | 10873 | 0.050 |
Why?
|
Carbon Monoxide | 2 | 2003 | 560 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8748 | 0.050 |
Why?
|
Consensus | 1 | 2012 | 3212 | 0.050 |
Why?
|
Heat-Shock Proteins | 2 | 2003 | 797 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3252 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39348 | 0.050 |
Why?
|
Internship and Residency | 2 | 2014 | 5953 | 0.050 |
Why?
|
Cytokines | 5 | 2003 | 7453 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16726 | 0.050 |
Why?
|
Survival Rate | 1 | 2014 | 12840 | 0.040 |
Why?
|
Receptors, Complement | 4 | 1995 | 254 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11244 | 0.040 |
Why?
|
Cholestasis | 1 | 2002 | 385 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10101 | 0.040 |
Why?
|
Mixed Connective Tissue Disease | 2 | 1989 | 32 | 0.040 |
Why?
|
Acute-Phase Proteins | 2 | 2015 | 252 | 0.040 |
Why?
|
Patient Care Team | 1 | 2009 | 2523 | 0.040 |
Why?
|
Interferon-gamma | 3 | 1992 | 3160 | 0.040 |
Why?
|
Registries | 2 | 2025 | 8375 | 0.040 |
Why?
|
Skin Care | 1 | 2018 | 55 | 0.040 |
Why?
|
Mice, Inbred Strains | 2 | 1990 | 1765 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13676 | 0.040 |
Why?
|
Colloids | 1 | 2017 | 125 | 0.030 |
Why?
|
Adult | 11 | 2024 | 223646 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 2020 | 416 | 0.030 |
Why?
|
Odds Ratio | 2 | 2020 | 9669 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10760 | 0.030 |
Why?
|
Austria | 1 | 2016 | 208 | 0.030 |
Why?
|
Drug Synergism | 2 | 1990 | 1760 | 0.030 |
Why?
|
Anti-Infective Agents, Local | 1 | 2018 | 247 | 0.030 |
Why?
|
Zymosan | 1 | 1995 | 134 | 0.030 |
Why?
|
Complement Pathway, Alternative | 1 | 1995 | 113 | 0.030 |
Why?
|
Anesthesia, General | 1 | 2022 | 1189 | 0.030 |
Why?
|
Bradykinin | 1 | 1995 | 205 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6498 | 0.030 |
Why?
|
Tidal Volume | 1 | 2017 | 518 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 1992 | 10266 | 0.030 |
Why?
|
Acid-Base Equilibrium | 1 | 2015 | 180 | 0.030 |
Why?
|
Carbohydrate Metabolism | 1 | 1995 | 262 | 0.030 |
Why?
|
Kidney Tubules, Proximal | 1 | 2016 | 386 | 0.030 |
Why?
|
Lipocalins | 1 | 2015 | 161 | 0.030 |
Why?
|
Germany | 1 | 2016 | 883 | 0.030 |
Why?
|
Substance P | 1 | 1995 | 332 | 0.030 |
Why?
|
Urinalysis | 1 | 2016 | 370 | 0.030 |
Why?
|
Myocardial Reperfusion | 1 | 1995 | 339 | 0.030 |
Why?
|
Prognosis | 1 | 2014 | 30010 | 0.030 |
Why?
|
Animals | 8 | 2013 | 169246 | 0.030 |
Why?
|
Cohort Studies | 2 | 2014 | 41754 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 642 | 0.030 |
Why?
|
Cells, Cultured | 5 | 2016 | 19015 | 0.030 |
Why?
|
Boston | 2 | 2016 | 9374 | 0.030 |
Why?
|
Renal Replacement Therapy | 1 | 2015 | 282 | 0.030 |
Why?
|
Pelvis | 1 | 2017 | 736 | 0.020 |
Why?
|
Nephrosis, Lipoid | 1 | 2012 | 46 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2016 | 771 | 0.020 |
Why?
|
Chemotactic Factors | 1 | 1992 | 197 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1157 | 0.020 |
Why?
|
Pulmonary Circulation | 1 | 2014 | 745 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 2014 | 408 | 0.020 |
Why?
|
Polymyxin B | 1 | 1990 | 44 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 40218 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 4 | 1992 | 660 | 0.020 |
Why?
|
Kidney Tubules | 1 | 2012 | 454 | 0.020 |
Why?
|
Emergencies | 1 | 2017 | 1221 | 0.020 |
Why?
|
Monocytes | 3 | 1992 | 2605 | 0.020 |
Why?
|
Peritoneal Cavity | 1 | 1990 | 135 | 0.020 |
Why?
|
Colony-Stimulating Factors | 1 | 1990 | 218 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14729 | 0.020 |
Why?
|
Apoptosis | 2 | 2003 | 9523 | 0.020 |
Why?
|
Neutrophils | 2 | 1995 | 3786 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2014 | 877 | 0.020 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2011 | 198 | 0.020 |
Why?
|
Health Services Research | 1 | 2016 | 1815 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 42669 | 0.020 |
Why?
|
Biological Factors | 1 | 1990 | 156 | 0.020 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1990 | 381 | 0.020 |
Why?
|
Hemoglobins | 1 | 2015 | 1531 | 0.020 |
Why?
|
Blotting, Northern | 1 | 1990 | 1550 | 0.020 |
Why?
|
Young Adult | 4 | 2016 | 60066 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2012 | 1888 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8542 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 1240 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1643 | 0.020 |
Why?
|
Growth Substances | 1 | 1990 | 759 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2012 | 12800 | 0.020 |
Why?
|
Preoperative Care | 1 | 2017 | 2258 | 0.020 |
Why?
|
Hypotension | 1 | 2014 | 888 | 0.020 |
Why?
|
Demography | 1 | 2012 | 1641 | 0.020 |
Why?
|
Liver | 1 | 2003 | 7577 | 0.020 |
Why?
|
Epithelial Cells | 2 | 2016 | 3703 | 0.020 |
Why?
|
Hospitalization | 2 | 2017 | 10840 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1990 | 892 | 0.020 |
Why?
|
Postoperative Care | 1 | 2013 | 1480 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1990 | 1353 | 0.020 |
Why?
|
Mice, Inbred BALB C | 2 | 2012 | 6231 | 0.020 |
Why?
|
Communication Barriers | 1 | 2009 | 419 | 0.020 |
Why?
|
Risk Management | 1 | 2009 | 558 | 0.020 |
Why?
|
Organizational Culture | 1 | 2009 | 513 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 1995 | 2819 | 0.020 |
Why?
|
Anesthesia | 1 | 2017 | 1596 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 2012 | 1039 | 0.020 |
Why?
|
Transfer Factor | 1 | 1985 | 5 | 0.020 |
Why?
|
Europe | 1 | 2012 | 3436 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4860 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1989 | 549 | 0.020 |
Why?
|
Swine | 1 | 1995 | 5995 | 0.010 |
Why?
|
Hodgkin Disease | 2 | 1985 | 1384 | 0.010 |
Why?
|
United States | 3 | 2024 | 73039 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 1995 | 2138 | 0.010 |
Why?
|
Adolescent | 2 | 2012 | 89169 | 0.010 |
Why?
|
Skin | 1 | 2018 | 4503 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 1995 | 3044 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2014 | 2258 | 0.010 |
Why?
|
Interdisciplinary Communication | 1 | 2009 | 937 | 0.010 |
Why?
|
Child | 1 | 2012 | 80917 | 0.010 |
Why?
|
Receptors, Complement 3b | 3 | 1989 | 136 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2010 | 1967 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4146 | 0.010 |
Why?
|
Hypertension, Pulmonary | 1 | 2014 | 1605 | 0.010 |
Why?
|
Cell Movement | 1 | 1995 | 5210 | 0.010 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2012 | 1250 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4528 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 2014 | 1932 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2011 | 2227 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 1989 | 1854 | 0.010 |
Why?
|
Antigens, CD | 1 | 1992 | 4035 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 1995 | 11095 | 0.010 |
Why?
|
Information Dissemination | 1 | 2009 | 1143 | 0.010 |
Why?
|
Contrast Media | 1 | 2014 | 5330 | 0.010 |
Why?
|
Mice | 4 | 2012 | 82029 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 13014 | 0.010 |
Why?
|
Clinical Competence | 1 | 2016 | 4858 | 0.010 |
Why?
|
Levamisole | 1 | 1980 | 36 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18412 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14783 | 0.010 |
Why?
|
Rosette Formation | 2 | 1989 | 152 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1990 | 5505 | 0.010 |
Why?
|
Massachusetts | 1 | 2012 | 8890 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12465 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1990 | 2257 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 22291 | 0.010 |
Why?
|
Phagocytosis | 3 | 1989 | 1530 | 0.010 |
Why?
|
Gene Expression | 1 | 1990 | 7598 | 0.010 |
Why?
|
Rats | 1 | 2012 | 23760 | 0.010 |
Why?
|
Cell Line | 1 | 1990 | 15597 | 0.010 |
Why?
|
Antigen-Antibody Complex | 2 | 1989 | 513 | 0.010 |
Why?
|
Neuraminidase | 1 | 1995 | 195 | 0.010 |
Why?
|
L-Selectin | 1 | 1995 | 212 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26379 | 0.010 |
Why?
|
Receptors, Fc | 2 | 1989 | 537 | 0.010 |
Why?
|
Hospitals | 1 | 2007 | 3886 | 0.010 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 1992 | 221 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20760 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 1992 | 4352 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 1992 | 605 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 1995 | 1613 | 0.000 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1989 | 317 | 0.000 |
Why?
|
Signal Transduction | 1 | 1992 | 23645 | 0.000 |
Why?
|
Cell Adhesion | 1 | 1995 | 3096 | 0.000 |
Why?
|
Integrins | 1 | 1992 | 842 | 0.000 |
Why?
|
Lymphoproliferative Disorders | 1 | 1990 | 528 | 0.000 |
Why?
|
Alkaline Phosphatase | 1 | 1989 | 863 | 0.000 |
Why?
|
Leukocyte Count | 1 | 1989 | 1609 | 0.000 |
Why?
|
Down-Regulation | 1 | 1990 | 2937 | 0.000 |
Why?
|
Chemotaxis | 1 | 1985 | 600 | 0.000 |
Why?
|
Bone Marrow | 1 | 1990 | 2935 | 0.000 |
Why?
|
Lymphocytes | 1 | 1985 | 2614 | 0.000 |
Why?
|